IFNG and COVID-19: This is in line with recent findings describing increased gene expression in response to IFN-γ in Mild and Severe COVID-19 patients in peripheral myeloid cells (39) and the dysregulation in the balance of monocyte populations by the expansion of the monocyte subsets described in COVID-19 patients (39).